LOXO-101: Additional Phase I data

Loxo said 1 female patient with advanced soft tissue sarcoma (STS) metastatic to the lungs harboring a Trk gene fusion who received twice-daily 100 mg oral LOXO-101 in an open-label, dose-escalation, ...